5 Luteina creste functia vizuala la pacienti cu cataracta, studiu randomizat
dublu orb placebo controlat
6 Nivelul plasmatic de Luteina si Zeaxantina la maculopatie si cataracta
7 Luteina si Zeaxantina si in protectia degenerarii maculare
Pacientul acopera un ochi si
priveste punctul daca vederea devine ondulatorie poate fi caz
de degenerescenta maculara.
Degenerescenta maculara
8 Luteina cu efect in formarea pigmentului macular, studiu de 140 zile
9 Influenta de Suplimente cu Luteina la pigmentul macular
10 Nivelul plasmatic de Luteina la persoane cu si fara maculopatie, studiu pilot
11 Luteina si Zeaxantina la maculopatie
12 Concentratia de Luteina si Zeaxantina la densitatea pigmentului macular
13 Luteina un antioxidant in interventia la degenerarea pigmentului macular,
studiu randomizat dublu orb placebo controlat
14 Luteina si Zeaxantina caretenoizi la bolile ochilor ca degenerescenta maculara
15 Prin Suplimentarea de caretenoizi Luteina si Zeaxantina se schimba densitatea
pigmentului macular
16 Distributia de Luteina si Zeaxantina in retina umana
17 Acumularea de xantofili in retina umana dupa administrarea de Luteina si
Zeaxantina
18 Luteina creste functia vizuala la pacienti cu degenerescenta retinala, studiu
pilot
19 Caretenoizii retinali Luteina si Zeaxantina ca antioxidant neutralizeaza
radicalii liberi, studiu de chemiluminiscenta
Luteina - Flora Glo® - Luteina
si Zeaxantina de la Marigold
20 Luteina si Zeaxantina caretenoizi cu efect la nivelul plasmatic persoanelor
de 60 de ani sau mai in varsta
21 Luteina si Zeaxantina reduce proliferarea indusa de razelor ultraviolete
UV-B si inflamatia
22 Luteina si Zeaxantina reduce imbatranirea indusa de lumina si foto carcinogeneza
la iradiatia cronica de UV-B
23 Luteina si Zeaxantina cu activitate
anti tumorala influentata de gruparea radicalului hidroxil
24 Luteina cu efect profilactic la progresia de ateroscleroza, studiu
Bibliografie - Referinte Luteina si Zeaxantina
Informatii din bibliografia electronica la tema: Nutritie si sanatate
1 Semba RD, Dagnelie G. Are lutein and zeaxanthin conditionally essential nutrients
for eye health? Med Hypotheses. 2003 Oct;61(4):465-72.
2 Palombo P, Fabrizi G,
Ruocco V, et al. Beneficial long-term effects of combined oral/topical antioxidant
treatment with the carotenoids lutein and zeaxanthin
on human skin: a double-blind, placebo-controlled study. Skin Pharmacol Physiol.
2007;20(4):199-210.
3 Palombo, P., P. Morganti, et al. (2006). “New
evidence for efficacy of lutein/zeaxanthin in skin health. Beyond Beauty Paris
2006 Conference Abstract.
4 Alves-Rodrigues A, Shao A. The science behind lutein. Toxicol Lett. 2004 Apr
15;150(1):57-83.
5 Olmedilla B, Granado F, Blanco I, Vaquero M. Lutein, but not alpha-toco- pherol,
supplementation improves visual function in patients with age-related cataracts:
a 2-y double-blind, placebo-con- trolled pilot study. Nutrition. 2003 Jan;19(1):21-4.
6 Delcourt C, Carriere I, Delage M, Barberger-Gateau P,
Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable
risk factors for age-related maculopathy and cataract: the POLA Study.
Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2329-35.
7 Mozaffarieh
M, Sacu S, Wedrich A. The role of the carotenoids, lutein and zeaxanthin, in
protecting
against age-related macular degeneration: A review
based on controversial evidence. Nutr J. 2003 Dec 11;2(1):20.
8 Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year
study of the macular pigment: the effect of 140 days of a lutein supplement.
Exp
Eye Res. 1997 Jul;65(1):57-62.
9 Berendschot TT, Goldbohm RA, Klopping WA, van de Kraats J, van Norel J,
van Norren D. Influence of lutein supplementation on macular pigment, assessed
with two objective techniques. Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3322-6.
10 Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular
responses to lutein supplement in subjects with and without age-related maculopathy:
a pilot study. Exp Eye Res. 2004 Jul;79(1):21-7.
11 Mares-Perlman
et al., "Lutein and Zeaxanthin in the Diet and Serum and Their Relation to Age-Related
Maculopathy in the Third National Health and Nutrition Examination Survey," American Journal of Epidemiology, 2001, Vol. 153, No. 5, pgs. 424-432.
- Delcourt, C.J. Cristol, F. Tessier, C.L. Leger, B. Descomps, L. Papoz, and
the POLA Study Group. "Age-related
Macular Degeneration and Antioxidant
Status in the POLA Study," Arch. Ophthalmol. Vol. 117 (October 1999), pp.
1384.
12 Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue
con- centrations of lutein and zeaxanthin and macular pigment density. Am J
Clin
Nutr. 2000 Jun;71(6):1555-62.
13 Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled,
ran- domized trial of lutein and antioxidant supplementation in the intervention
of atrophic age-related macular degenera- tion: the Veterans LAST study (Lutein
Antioxidant Supplement Trial). Optometry. 2004 Apr;75(4):216-30.
14 Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate
age-related macular degeneration and lutein and zeaxanthin in the Carotenoids
in Age-related
Eye Disease Study (CAREDS): ancillary study of the Women’s
Health Initiative.
Arch Ophthalmol. 2006 Aug;124(8):1151-62.
15 Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical
density and serum concentrations of its constituent carotenoids following supplemental
lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007 Apr;84(4):718-28.
16 Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin
stereoisomers in the human retina. Exp Eye Res. 1997 Feb;64(2):211-8.
17 Schalch W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human
retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein
Xanthophyll
Eye Accumulation) study. Arch Biochem Biophys. 2007 Feb 15;458(2):128-35.
18 Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some
patients with retinal degeneration: a pilot study via the Internet. Optometry.
2000
Mar;71(3):147-64.
19 Trevithick-Sutton CC, Foote CS, Collins M, Trevithick JR. The retinal carotenoids
zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemiluminescence
and ESR study. Mol Vis. 2006;12:1127-35.
20 Khachik F, de Moura FF, Chew EY, et al. The effect of lutein and zeaxanthin
supplementation on metabolites of these carotenoids in the serum of persons
aged 60 or older. Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5234-42.
21 Gonzalez, S., S. Astner, et al. (2003). “Dietary
lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation
and acute inflammation
in hairless mice.” J Invest Dermatol 121:399-405.
22 Astner S, Wu A, Chen J, et al. Dietary lutein/zeaxanthin partially reduces
photoaging and photocarcinogenesis in chronically UVB-irradiated Skh-1 hairless
mice.
Skin Pharmacol Physiol. 2007;20(6):283-91.
23 Sun Z, Yao H. The influence of di-acetylation of the hydroxyl groups on the
anti-tumor-proliferation activity of lutein and zeaxanthin. Asia Pac J Clin
Nutr. 2007;16 Suppl 1:447-52.
24 Dwyer JH, Navab M, Dwyer KM, et al. Oxygenated carotenoid lutein and progression
of early atherosclerosis: the Los Angeles atherosclerosis study. Circulation.
2001 Jun 19;103(24):2922-7.
Parerea din pasajele acestui site nu a fost independent cercetate sau confirmate.